Treatment of Lyme disease soon after a tick bite can be straight forward. However, a significant number of people go on to develop chronic or persistent Lyme disease, which can be more difficult to treat successfully. Chronic Lyme disease may occur if someone was not treated following a tick bite (some people don’t recall a having a tick bite), was not effectively treated after a tick bite, or got co-infections from a tick bite that were not treated.
There are many treatments available for persistent Lyme disease and associated infections. Some treatments are based on scientific studies or empirical evidence, while others are marketed as effective therapies without any data to back up claims.
Other influences play a role in whether or not the treatment of Lyme disease and other tickborne infections is successful. Genetics and immune system health influence the outcome of persistent Lyme disease treatment. Environmental exposure, such as mold and heavy metals, can interfere with successfully treating Lyme disease and associated infections.
The articles below highlight some of the therapies I have found to be effective in treating tick-borne infections.
SOT For Lyme Disease
Supportive oligonucleotide therapy, or SOT, is a treatment that holds great promise in the fight against chronic infections. It involves the identification of gene sequences of various targets, such as Lyme disease and Epstein-Barr virus, from a blood sample. The lab then produces a specific oligonucleotide therapy to silence the infection’s genes needed for survival.…
Antibiotics for Chronic Lyme Disease
If you have learned that chronic Lyme disease is the underlying cause of your symptoms, the next hurdle is finding effective treatments. The conventional medical model believes Lyme disease can only last short-term, and if symptoms persist following treatment, there is another cause. However, multiple research studies have demonstrated that the bacteria that causes Lyme…
Low Dose Immunotherapy (LDI)
Most symptoms associated with chronic illnesses are a result of the immune response and subsequent inflammation. The immune response can directly damage tissue in the body or cause autoimmune antibodies to form. The immune and inflammatory activation goes beyond causing symptoms and contributes to the underlying pathophysiology of the condition. Low dose immunotherapy is a…
Treatment of Epstein-Barr Virus with IV Vitamin C
Epstein-Barr virus (EBV) is most commonly known as the cause of infectious mononucleosis. Most people are exposed to the Epstein-Barr virus early in life, so 90-95% of adults have memory antibodies against EBV and can remain asymptomatic their entire life. However, an active or reactivated infection with Epstein-Barr Virus can contribute to chronic fatigue syndrome…
Continue Reading Treatment of Epstein-Barr Virus with IV Vitamin C
Methylene Blue for Lyme Disease and Bartonella
Early in an infection, bacteria are in a growth phase where they divide rapidly to increase the number of bacteria to establish an infection. Bacteria then enter a stationary phase where bacterial growth slows down. The current antibiotic treatments for acute and chronic Lyme Disease and Bartonella primarily work in the bacterial growth phase. Still,…
Continue Reading Methylene Blue for Lyme Disease and Bartonella
Low Dose Naltrexone (LDN) for Lyme Disease
Naltrexone is a drug that was first discovered in 1963 to block opioid receptors. In 1984 naltrexone was approved by the FDA for alcohol and opiate addiction. At doses of 50-100mg, naltrexone blocks opiate receptors and prevent the euphoric sensation of alcohol or opiate drug consumption. Low dose naltrexone (LDN) has been used for a…
Ozone Therapy for Lyme Disease
Ozone therapy has been used successfully as a medical treatment for over 50 years. Ozone therapy is commonly used in European clinics, but recently, Americans are catching on to its benefits. Research studies have demonstrated ozone therapy may be helpful for supporting underlying pathophysiology associated with a range of health conditions, from Lyme disease to…